Patients Navigators in Facilitating Weight Management in Obese Participants

April 5, 2024 updated by: M.D. Anderson Cancer Center

Using Patient Navigators to Facilitate Weight Management Among Adults

This trial studies the effectiveness of patient navigators in facilitating weight management in obese participants. Health coaches or patient navigators may help more participants take part in weight management programs.

Study Overview

Detailed Description

PRIMARY OBJECTIVES:

I. To evaluate the effectiveness of patient navigators to increase enrollment in evidence-based weight management programs.

SECONDARY OBJECTIVES:

I. To evaluate the effectiveness of patient navigators to increase overall attendance or use of evidence-based weight management programs.

II. To evaluate the effectiveness of patient navigators to promoting and facilitating positive health behavior change: increased physical activity; improved diet; and weight loss.

OUTLINE: Participants are randomized to 1 of 2 groups.

GROUP I: Participants receive information about commercially-available weight management programs and encouragement to participate in one of the programs for 6 months.

GROUP II: Participants receive information about commercially-available weight management programs encouragement to participate in one of the programs for 6 months. Participants also receive 6 phone calls over 20-30 minutes each from an assigned patient navigator for 6 months.

After completion of the study, participants are followed up at 2 months.

Study Type

Interventional

Enrollment (Actual)

171

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • M D Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Are referred by a University of Texas (UT) health care provider
  • Have a body mass index (BMI) greater than or equal to 30 and less than or equal to 45 kg/m^2
  • Are able to read and speak English
  • Have a working telephone number and address where materials can be mailed
  • Able to engage in moderate intensity physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q)
  • Internet access at home or other location (e.g., work, church, library, community center, etc.)

Exclusion Criteria:

  • Another person in the same household already enrolled in the proposed intervention
  • Pregnant or thinking about becoming pregnant during the study period
  • Are already involved in another weight loss program
  • Participated in a weight loss, exercise, or dietary modification program in the previous 6 months
  • Involuntary or voluntary weight loss of greater than or equal to 5% body weight in the previous 6 months
  • Are currently using weight loss medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group I (information about weight management programs)
Participants receive information about commercially-available weight management programs and encouragement to participate in one of the programs for 6 months.
Ancillary studies
Receive information about weight management programs
Experimental: Group II (information, call from patient navigator)
Participants receive information about commercially-available weight management programs encouragement to participate in one of the programs for 6 months. Participants also receive 6 phone calls over 20-30 minutes each from an assigned patient navigator for 6 months.
Ancillary studies
Receive information about weight management programs
Receive phone calls from an assigned patient navigator

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in participant enrollment in evidence-based weight management programs
Time Frame: Up to 6 months
We will compare differences in the proportion of self-reported enrollment in any program between intervention and control groups.
Up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant attendance or use of evidence-based weight management programs
Time Frame: Up to 6 months
Attendance is a continuous variable and is defined as the total number of self-reported sessions attended or used by each participant.
Up to 6 months
Positive change in physical activity
Time Frame: Baseline up to 6 months
Accelerometer data will provide an objective assessment of physical activity (PA) We will calculate minutes of PA per week and meeting recommendations (yes/no).
Baseline up to 6 months
Measurement of fruit and vegetable consumption
Time Frame: Baseline up to 6 months
Fruit and vegetable consumption (i.e., # servings per day) will be measured using the 24 hour recall. Finally, objective measure of weight will be captured at each data collection time point.
Baseline up to 6 months
Objectively measured weight change.
Time Frame: Baseline up to 6 months
Change in body weight from baseline will be calculated.
Baseline up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lorna McNeill, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 2, 2015

Primary Completion (Estimated)

October 1, 2030

Study Completion (Estimated)

October 1, 2030

Study Registration Dates

First Submitted

September 10, 2018

First Submitted That Met QC Criteria

September 13, 2018

First Posted (Actual)

September 17, 2018

Study Record Updates

Last Update Posted (Actual)

April 8, 2024

Last Update Submitted That Met QC Criteria

April 5, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2015-0255 (Other Identifier: M D Anderson Cancer Center)
  • P30CA016672 (U.S. NIH Grant/Contract)
  • UL1TR000371 (U.S. NIH Grant/Contract)
  • NCI-2018-01819 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Questionnaire Administration

3
Subscribe